| 摘要 |
PROBLEM TO BE SOLVED: To provide a new use of phosphodiesterase 1 (PDE1) inhibitors.SOLUTION: The present invention relates to a new use of phosphodiesterase 1 (PDE1) inhibitors for the treatment of psychosis, schizophrenia, schizoaffective disorder, schizophreniform disorder, psychotic disorder, delusional disorder, mania, or bipolar disorder. |
